HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

huN901-DM1

a compound comprised of a CD56-targeted humanized N901 antibody conjugated to the company's proprietary cytotoxic agent. DM1, using its tumor-activated prodrug technology, for the potential treatment of cancers that express CD56, in particular, small-cell lung cancer
Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lambert, John M: 1 article (09/2005)
2. Amphlett, Godfrey: 1 article (09/2005)
3. Blättler, Walter A: 1 article (09/2005)
4. Wang, Lintao: 1 article (09/2005)
5. Zhang, Wei: 1 article (09/2005)
6. Carrasco, Daniel R: 1 article (07/2004)
7. Whiteman, Kathleen R: 1 article (07/2004)
8. Tassone, Pierfrancesco: 1 article (07/2004)
9. Allam, Charles K: 1 article (07/2004)
10. Gozzini, Antonella: 1 article (07/2004)

Related Diseases

1. Multiple Myeloma
2. Waldenstrom Macroglobulinemia (Macroglobulinemia)
3. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
4. Neoplasms (Cancer)

Related Drugs and Biologics

1. Immunoconjugates (Immunoconjugate)
2. Immunoglobulin G (IgG)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)